BridgeBio Pharma, Inc. (BBIO)
72.78
-1.67
(-2.24%)
USD |
NASDAQ |
Apr 02, 14:41
BridgeBio Pharma Research and Development Expense (TTM) : 451.95M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.25B |
| Insmed, Inc. | 771.09M |
| Mirum Pharmaceuticals, Inc. | 185.83M |
| Supernus Pharmaceuticals, Inc. | 104.15M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |